Deutsche Bank Ag\ Amneal Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

$245 Billion
Q1 2025

A detailed history of Deutsche Bank Ag\ transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 305,621 shares of AMRX stock, worth $2.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

305,621

Previous 133,886 128.27%

Holding current value

$2.48 Million

Previous $1.06 Million 141.6%

% of portfolio

0.0%

Previous 0.0%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$7.72 - $9.01 $1.33 Million - $1.55 Million	171,735 Added 128.27%	305,621 $2.56 Million
Q4 2024 Feb 14, 2025	BUY	$7.69 - $9.25 $346,557 - $416,860	45,066 Added 50.74%	133,886 $1.06 Million
Q3 2024 Jun 26, 2025	SELL	$6.42 - $8.83 $1.39 Million - $1.91 Million	-216,801 Reduced 70.94%	88,820 $738,000
Q3 2024 Nov 13, 2024	BUY	$6.42 - $8.83 $135,230 - $185,995	21,064 Added 31.09%	88,820 $738,000
Q2 2024 Jun 12, 2025	SELL	$5.36 - $7.11 $1.27 Million - $1.69 Million	-237,865 Reduced 77.83%	67,756 $430,000
Q2 2024 Aug 14, 2024	BUY	$5.36 - $7.11 $47,280 - $62,717	8,821 Added 14.97%	67,756 $430,000
Q1 2024 Jun 02, 2025	SELL	$5.24 - $6.34 $1.29 Million - $1.56 Million	-246,686 Reduced 80.72%	58,935 $357,000
Q1 2024 May 15, 2024	BUY	$5.24 - $6.34 $8,719 - $10,549	1,664 Added 2.91%	58,935 $357,000
Q4 2023 Feb 14, 2024	SELL	$3.36 - $6.21 $4,885 - $9,029	-1,454 Reduced 2.48%	57,271 $347,000
Q3 2023 Nov 09, 2023	SELL	$2.76 - $4.59 $638,227 - $1.06 Million	-231,242 Reduced 79.75%	58,725 $247,000
Q2 2023 Aug 14, 2023	SELL	$1.33 - $3.1 $25,364 - $59,120	-19,071 Reduced 6.17%	289,967 $898,000
Q1 2023 May 15, 2023	BUY	$1.27 - $2.7 $19,758 - $42,006	15,558 Added 5.3%	309,038 $429,000
Q4 2022 Feb 13, 2023	BUY	$1.96 - $2.61 $1,350 - $1,798	689 Added 0.24%	293,480 $584,000
Q3 2022 Nov 14, 2022	BUY	$2.02 - $3.62 $1,026 - $1,838	508 Added 0.17%	292,791 $591,000
Q2 2022 Aug 11, 2022	SELL	$3.01 - $4.46 $20,606 - $30,533	-6,846 Reduced 2.29%	292,283 $929,000
Q1 2022 May 13, 2022	SELL	$3.9 - $4.89 $25,088 - $31,457	-6,433 Reduced 2.11%	299,129 $1.25 Million
Q4 2021 Feb 11, 2022	BUY	$3.95 - $5.85 $963,918 - $1.43 Million	244,030 Added 396.59%	305,562 $1.46 Million
Q3 2021 Nov 04, 2021	SELL	$4.31 - $5.64 $7,943 - $10,394	-1,843 Reduced 2.91%	61,532 $328,000
Q2 2021 Aug 11, 2021	SELL	$5.12 - $6.82 $22,256 - $29,646	-4,347 Reduced 6.42%	63,375 $324,000
Q1 2021 May 13, 2021	SELL	$4.74 - $7.38 $28,601 - $44,530	-6,034 Reduced 8.18%	67,722 $455,000
Q4 2020 Feb 16, 2021	SELL	$3.95 - $5.42 $27,890 - $38,270	-7,061 Reduced 8.74%	73,756 $337,000
Q3 2020 Nov 12, 2020	SELL	$3.54 - $5.27 $378,872 - $564,027	-107,026 Reduced 56.98%	80,817 $313,000
Q2 2020 Aug 13, 2020	BUY	$2.87 - $5.46 $354,912 - $675,199	123,663 Added 192.68%	187,843 $895,000
Q1 2020 May 14, 2020	SELL	$2.46 - $5.35 $289,512 - $629,630	-117,688 Reduced 64.71%	64,180 $224,000
Q4 2019 Feb 14, 2020	BUY	$2.65 - $5.56 $180,223 - $378,130	68,009 Added 59.73%	181,868 $875,000
Q3 2019 Nov 14, 2019	BUY	$2.29 - $7.1 $55,154 - $171,003	24,085 Added 26.83%	113,859 $329,000
Q2 2019 Aug 14, 2019	SELL	$6.44 - $14.29 $1.11 Million - $2.45 Million	-171,700 Reduced 65.67%	89,774 $641,000
Q1 2019 May 15, 2019	BUY	$11.87 - $14.84 $507,703 - $634,736	42,772 Added 19.56%	261,474 $3.7 Million
Q4 2018 Feb 14, 2019	BUY	$13.09 - $21.49 $287,966 - $472,758	21,999 Added 11.18%	218,702 $2.96 Million
Q3 2018 Dec 21, 2021	BUY	$16.4 - $24.27 $374,182 - $553,744	22,816 Added 13.12%	196,703 $4.37 Million
Q3 2018 Nov 14, 2018	SELL	$16.4 - $24.27 $424,513 - $628,228	-25,885 Reduced 12.96%	173,887 $3.86 Million
Q2 2018 Apr 21, 2020	BUY	$13.95 - $20.2 $439,048 - $635,754	31,473 Added 18.7%	199,772 $3.28 Million
Q2 2018 Aug 14, 2018	BUY	$13.95 - $20.2 $2.35 Million - $3.4 Million	168,299 New	168,299 $2.76 Million

Others Institutions Holding AMRX

# of Institutions

244

Shares Held

136M

Call Options Held

302K

Put Options Held

103K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.23B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account